Us2.ai Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$15.1M
- Investors
-
19
Us2.ai General Information
Description
Operator of a machine learning platform intended to provide partners with an end-to-end resolution for cardiovascular research, development, and distribution. The company's platform automates the manual process of measuring and interpreting echocardiograms and provides artificial intelligence-based decision support tools to save doctors time, improve clinical trials for pharma, and support the detection of routinely missed and hard-to-diagnose conditions for hospitals, enabling physicians to improve the performance of cardiovascular clinical trials.
Contact Information
Website
www.us2.aiCorporate Office
- 72 Circular Road
- Suite 03-01
- Singapore, 169850
- Singapore
Corporate Office
- 72 Circular Road
- Suite 03-01
- Singapore, 169850
- Singapore
Us2.ai Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 14-Apr-2022 | $15.1M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | 07-Jul-2020 | Completed | Generating Revenue | |||
| 5. Seed Round | 07-Jan-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jun-2019 | Completed | Startup | |||
| 3. Accelerator/Incubator | 26-Apr-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Us2.ai Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Us2.ai Comparisons
Industry
Financing
Details
Us2.ai Competitors (4)
One of Us2.ai’s 4 competitors is Ultromics, a Venture Capital-Backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ultromics | Venture Capital-Backed | Oxford, United Kingdom | ||||
| Caption Care | Formerly VC-backed | San Mateo, CA | ||||
| Ligence | Venture Capital-Backed | Vilnius, Lithuania | ||||
| DiA Imaging Analysis | Formerly VC-backed | Beer Sheva, Israel |
Us2.ai Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Us2.ai Patents
Us2.ai Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240374234-A1 | Automatic clinical workflow that recognizes and analyzes 2d and doppler modality echocardiogram images for automated cardiac measurements and grading of mitral valve and tricuspid valve regurgitation severity | Inactive | 10-May-2023 | ||
| US-11931207-B2 | Artificial intelligence (ai) recognition of echocardiogram images to enhance a mobile ultrasound device | Active | 11-Dec-2018 | ||
| US-20210259664-A1 | Artificial intelligence (ai) recognition of echocardiogram images to enhance a mobile ultrasound device | Active | 11-Dec-2018 | ||
| US-12001939-B2 | Artificial intelligence (ai)-based guidance for an ultrasound device to improve capture of echo image views | Active | 11-Dec-2018 | ||
| US-20210264238-A1 | Artificial intelligence (ai)-based guidance for an ultrasound device to improve capture of echo image views | Active | 11-Dec-2018 | G06N3/08 |
Us2.ai Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Us2.ai Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BFA Global Investors | Family Office | Minority | ||
| East Post Road Ventures | Corporate Venture Capital | Minority | ||
| FJ Labs | Venture Capital | Minority | ||
| HEAL Partners Management | Growth/Expansion | Minority | ||
| IHH Healthcare | Holding Company | Minority |
Us2.ai FAQs
-
When was Us2.ai founded?
Us2.ai was founded in 2017.
-
Where is Us2.ai headquartered?
Us2.ai is headquartered in Singapore, Singapore.
-
What is the size of Us2.ai?
Us2.ai has 32 total employees.
-
What industry is Us2.ai in?
Us2.ai’s primary industry is Decision/Risk Analysis.
-
Is Us2.ai a private or public company?
Us2.ai is a Private company.
-
What is the current valuation of Us2.ai?
The current valuation of Us2.ai is .
-
What is Us2.ai’s current revenue?
The current revenue for Us2.ai is .
-
How much funding has Us2.ai raised over time?
Us2.ai has raised $20.8M.
-
Who are Us2.ai’s investors?
BFA Global Investors, East Post Road Ventures, FJ Labs, HEAL Partners Management, and IHH Healthcare are 5 of 19 investors who have invested in Us2.ai.
-
Who are Us2.ai’s competitors?
Ultromics, Caption Care, Ligence, and DiA Imaging Analysis are competitors of Us2.ai.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
